Sham R L, Raubertas R F, Braggins C, Cappuccio J, Gallagher M, Phatak P D
Department of Medicine, Rochester General Hospital, NY 14621, USA.
Blood. 2000 Dec 1;96(12):3707-11.
Screening for hereditary hemochromatosis (HHC) by means of transferrin saturation (TS) levels has been advocated and will identify many patients who are asymptomatic. The purposes of this study were (1) to determine HFE genotypes among asymptomatic HHC patients and correlate this profile with the degree of iron overload and (2) to evaluate the relationship between mobilized iron (mob Fe), age, serum ferritin (SF), and quantitative hepatic iron (QHI) in this population. One hundred twenty-three asymptomatic HHC patients were evaluated; all had quantitative phlebotomy to determine mob Fe and genotyping for C282Y and H63D mutations. Liver biopsies with QHI determinations were performed on 72 of the 123 patients. Of the entire group, 60% were homozygous for C282Y, and 13% were compound heterozygotes (C282Y/H63D). Among asymptomatic patients, the prevalence of homozygous C282Y is lower compared with previous studies that include clinically affected patients. Of those patients with more than 4 g mob Fe, 77% were homozygous C282Y. Asymptomatic patients with lower iron burdens frequently had genotypes other than homozygous C282Y. There was no correlation between age and mob Fe in these patients; however, there was a correlation between mob Fe and both SF (r = 0.68) and QHI (r = 0.75). In conclusion, asymptomatic patients with moderate iron overload had a different genotypic profile than was seen in advanced iron overload. The significance of identifying patients with modest degrees of iron loading, who may not be homozygous for C282Y, must be addressed if routine TS screening is to be implemented. (Blood. 2000;96:3707-3711)
通过转铁蛋白饱和度(TS)水平筛查遗传性血色素沉着症(HHC)已得到提倡,且能识别出许多无症状患者。本研究的目的是:(1)确定无症状HHC患者的HFE基因型,并将此情况与铁过载程度相关联;(2)评估该人群中动员铁(mob Fe)、年龄、血清铁蛋白(SF)和定量肝铁(QHI)之间的关系。对123例无症状HHC患者进行了评估;所有患者均接受定量静脉放血以确定mob Fe,并对C282Y和H63D突变进行基因分型。123例患者中的72例进行了肝活检及QHI测定。在整个研究组中,60%为C282Y纯合子,13%为复合杂合子(C282Y/H63D)。在无症状患者中,与既往纳入有临床症状患者的研究相比,C282Y纯合子的患病率较低。在那些mob Fe超过4g的患者中,77%为C282Y纯合子。铁负荷较低的无症状患者通常具有非C282Y纯合子的基因型。这些患者的年龄与mob Fe之间无相关性;然而,mob Fe与SF(r = 0.68)和QHI(r = 0.75)均存在相关性。总之,中度铁过载的无症状患者具有与重度铁过载患者不同的基因型特征。如果要实施常规TS筛查,就必须解决识别铁负荷程度较轻且可能不是C282Y纯合子患者的意义问题。(《血液》。2000年;96:3707 - 3711)